Increased susceptibility to Trichuris muris infection and exacerbation of colitis in Mdr1a-/- mice

World Journal of Gastroenterology

Volumn 20, Issue 7, 2014, Pages 1797-1806

  Bhardwaj, Ekta K ^a   Else, Kathryn J ^b   Rogan, Michael T ^a   Warhurst, Geoffrey ^a,c  

^a UNIVERSITY OF SALFORD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Colitis; Helminth; Inflammatory bowel disease; Mdr1a; P glycoprotein

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 5; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; IMMUNOHISTOCHEMISTRY; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; TRICHURIASIS; ANIMAL; CD4+ T LYMPHOCYTE; COMPLICATION; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION; GENETICS; INFLAMMATORY BOWEL DISEASES; KNOCKOUT MOUSE; LYMPH NODE; MALE; METABOLISM; PARASITOLOGY; PATHOLOGY; TRICHURIS;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLITIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; INFLAMMATORY BOWEL DISEASES; LYMPH NODES; MALE; MICE; MICE, KNOCKOUT; P-GLYCOPROTEIN; P-GLYCOPROTEINS; TRICHURIASIS; TRICHURIS;

EID: 84894232420     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i7.1797     Document Type: Article

References (35)

1. Cliffe LJ, Grencis RK. The Trichuris muris system: a paradigm of resistance and susceptibility to intestinal nematode infection. Adv Parasitol 2004; 57: 255-307 [PMID: 15504540 DOI: 10.1016/S0065-308X(04)57004-5]
2. Else KJ. Have gastrointestinal nematodes outwitted the immune system? Parasite Immunol 2005; 27: 407-415 [PMID: 16179034. DOI: 10.1111/j.1365-3024.2005.00788.x]
3. Wang LJ, Cao Y, Shi HN. Helminth infections and intestinal inflammation. World J Gastroenterol 2008; 14: 5125-5132 [PMID: 18777588 DOI: 10.3748/wjg.14.5125]
4. Summers RW, Elliott DE, Urban JF, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut 2005; 54: 87-90 [PMID: 15591509 DOI: 10.1136/gut.2004.041749]
5. Summers RW, Elliott DE, Urban JF, Thompson RA, Weinstock JV. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005; 128: 825-832 [PMID: 15825065 DOI: 10.1053/j.gastro.2005.01.005]
6. Levison SE, McLaughlin JT, Zeef LA, Fisher P, Grencis RK, Pennock JL. Colonic transcriptional profiling in resistance and susceptibility to trichuriasis: phenotyping a chronic colitis and lessons for iatrogenic helminthosis. Inflamm Bowel Dis 2010; 16: 2065-2079 [PMID: 20687192 DOI: 10.1002/ ibd.21326]
7. Weinstock JV, Elliott DE. Translatability of helminth therapy in inflammatory bowel diseases. Int J Parasitol 2013; 43: 245-251 [PMID: 23178819 DOI: 10.1016/j.ijpara.2012.10.016]
8. Wilson MS, Ramalingam TR, Rivollier A, Shenderov K, Mentink-Kane MM, Madala SK, Cheever AW, Artis D, Kelsall BL, Wynn TA. Colitis and intestinal inflammation in IL10-/-mice results from IL-13Rα2-mediated attenuation of IL-13 activity. Gastroenterology 2011; 140: 254-264 [PMID: 20951137. DOI: 10.1053/j.gastro.2010.09.047]
9. Panwala CM, Jones JC, Viney JL. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998; 161: 5733-5744 [PMID: 9820555]
10. Maggio-Price L, Shows D, Waggie K, Burich A, Zeng W, Escobar S, Morrissey P, Viney JL. Helicobacter bilis infection accelerates and H. hepaticus infection delays the development of colitis in multiple drug resistance-deficient (mdr1a-/-) mice. Am J Pathol 2002; 160: 739-751 [PMID: 11839595. DOI: 10.1016/S0002-9440(10)64894-8]
11. Collett A, Higgs NB, Gironella M, Zeef LA, Hayes A, Salmo E, Haboubi N, Iovanna JL, Carlson GL, Warhurst G. Early molecular and functional changes in colonic epithelium that precede increased gut permeability during colitis development in mdr1a(-/-) mice. Inflamm Bowel Dis 2008; 14: 620-631 [PMID: 18275070 DOI: 10.1002/ibd.20375]
12. Datta R, deSchoolmeester ML, Hedeler C, Paton NW, Brass AM, Else KJ. Identification of novel genes in intestinal tissue that are regulated after infection with an intestinal nematode parasite. Infect Immun 2005; 73: 4025-4033 [PMID: 15972490 DOI: 10.1128/IAI.73.7.4025-4033.2005]
13. Wakelin D. Acquired immunity to Trichuris muris in the albino laboratory mouse. Parasitology 1967; 57: 515-524 [PMID: 6048569. DOI: 10.1017/S0031182000072395]
14. Else KJ, Wakelin D, Wassom DL, Hauda KM. The influence of genes mapping within the major histocompatibility complex on resistance to Trichuris muris infections in mice. Parasitology 1990; 101 Pt 1: 61-67 [PMID: 2235076 DOI: 10.1017/ S0031182000079762]
15. Else KJ, Entwistle GM, Grencis RK. Correlations between worm burden and markers of Th1 and Th2 cell subset induction in an inbred strain of mouse infected with Trichuris muris. Parasite Immunol 1993; 15: 595-600 [PMID: 7877836]
16. Else K, Wakelin D. The effects of H-2 and non-H-2 genes on the expulsion of the nematode Trichuris muris from inbred and congenic mice. Parasitology 1988; 96 (Pt 3): 543-550 [PMID: 3136419. DOI: 10.1017/S0031182000080173]
17. Blackwell NM, Else KJ. A comparison of local and peripheral parasite-specific antibody production in different strains of mice infected with Trichuris muris. Parasite Immunol 2002; 24: 203-211 [PMID: 12010485 DOI: 10.1046/ j.1365-3024.2002.00452.x]
18. Bell LV, Else KJ. Regulation of colonic epithelial cell turnover by IDO contributes to the innate susceptibility of SCID mice to Trichuris muris infection. Parasite Immunol 2011; 33: 244-249 [PMID: 21392042 DOI: 10.1111/ j.1365-3024.2010.01272.x]
19. Bancroft AJ, Else KJ, Grencis RK. Low-level infection with Trichuris muris significantly affects the polarization of the CD4 response. Eur J Immunol 1994; 24: 3113-3118 [PMID: 7805740. DOI: 10.1002/eji.1830241230]
20. Else KJ, Finkelman FD, Maliszewski CR, Grencis RK. Cytokine-mediated regulation of chronic intestinal helminth infection. J Exp Med 1994; 179: 347-351 [PMID: 8270879 DOI: 10.1084/jem.179.1.347]
21. Hepworth MR, Grencis RK. Disruption of Th2 immunity results in a gender-specific expansion of IL-13 producing accessory NK cells during helminth infection. J Immunol 2009; 183: 3906-3914 [PMID: 19692641 DOI: 10.4049/jimmunol. 0900577]
22. Taylor BC, Zaph C, Troy AE, Du Y, Guild KJ, Comeau MR, Artis D. TSLP regulates intestinal immunity and inflammation in mouse models of helminth infection and colitis. J Exp Med 2009; 206: 655-667 [PMID: 19273626 DOI: 10.1084/ jem.20081499]
23. Elliott DE, Summers RW, Weinstock JV. Helminths and the modulation of mucosal inflammation. Curr Opin Gastroenterol 2005; 21: 51-58 [PMID: 15687885]
24. Hunter MM, Wang A, McKay DM. Helminth infection enhances disease in a murine TH2 model of colitis. Gastroenterology 2007; 132: 1320-1330 [PMID: 17408663 DOI: 10.1053/ j.gastro.2007.01.038]
25. Wang A, Fernando M, Leung G, Phan V, Smyth D, McKay DM. Exacerbation of oxazolone colitis by infection with the helminth Hymenolepis diminuta: involvement of IL-5 and eosinophils. Am J Pathol 2010; 177: 2850-2859 [PMID: 21037078. DOI: 10.2353/ajpath.2010.100537]
26. Hunter MM, Wang A, Hirota CL, McKay DM. Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol 2005; 174: 7368-7375 [PMID: 15905584]
27. Chen CC, Louie S, McCormick B, Walker WA, Shi HN. Concurrent infection with an intestinal helminth parasite impairs host resistance to enteric Citrobacter rodentium and enhances Citrobacter-induced colitis in mice. Infect Immun 2005; 73: 5468-5481 [PMID: 16113263 DOI: 10.1128/ IAI.73.9.5468-5481.2005]
28. Elliott DE, Setiawan T, Metwali A, Blum A, Urban JF, Weinstock JV. Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol 2004; 34: 2690-2698 [PMID: 15368285 DOI: 10.1002/eji.200324833]
29. Blum AM, Hang L, Setiawan T, Urban JP, Stoyanoff KM, Leung J, Weinstock JV. Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol 2012; 189: 2512-2520 [PMID: 22844110 DOI: 10.4049/jimmunol. 1102892]
30. Elliott DE, Weinstock JV. Where are we on worms? Curr Opin Gastroenterol 2012; 28: 551-556 [PMID: 23079675 DOI: 10.1097/MOG.0b013e3283572f73]
31. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1756-1767 [PMID: 21530742 DOI: 10.1053/ j.gastro.2011.02.016]
32. Geremia A, Jewell DP. The IL-23/IL-17 pathway in inflammatory bowel disease. Expert Rev Gastroenterol Hepatol 2012; 6: 223-237 [PMID: 22375527 DOI: 10.1586/egh.11.107]
33. Fasnacht N, Greweling MC, Bollati-Fogolín M, Schippers A, Müller W. T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection. Eur J Immunol 2009; 39: 2173-2183 [PMID: 19593768. DOI: 10.1002/eji.200838710]
34. Sandborn WJ, Elliott DE, Weinstock J, Summers RW, Landry-Wheeler A, Silver N, Harnett MD, Hanauer SB. Randomised clinical trial: the safety and tolerability of Trichuris suis ova in patients with Crohn's disease. Aliment Pharmacol Ther 2013; 38: 255-263 [PMID: 23730956 DOI: 10.1111/ apt.12366]
35. Tilp C, Kapur V, Loging W, Erb KJ. Prerequisites for the pharmaceutical industry to develop and commercialise helminths and helminth-derived product therapy. Int J Parasitol 2013; 43: 319-325 [PMID: 23291462 DOI: 10.1016/ j.ijpara.2012.12.003]